Opus Genetics Inc (IRD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 3,079 | 2,882 | 4,370 | 4,302 | 3,867 |
| Gross Profit | 3,079 | 2,882 | 4,370 | 4,302 | 3,867 |
| Operating Expenses | 11,390 | 11,788 | 14,299 | 42,331 | 11,876 |
| Operating Income | -8,311 | -8,906 | -9,929 | -38,029 | -8,009 |
| Interest Expense | 68 | 0 | 0 | 0 | 0 |
| Other Income | -9,075 | 1,486 | 1,735 | 2,894 | 483 |
| Pre-tax Income | -17,454 | -7,420 | -8,194 | -35,135 | -7,526 |
| Net Income Continuous | -17,454 | -7,420 | -8,194 | -35,135 | -7,526 |
| Net Income | $-17,454 | $-7,420 | $-8,194 | $-35,135 | $-7,526 |
| EPS Basic Total Ops | -0.25 | -0.12 | -0.24 | -1.27 | -0.29 |
| EPS Basic Continuous Ops | -0.25 | -0.12 | -0.24 | -1.28 | -0.29 |
| EPS Diluted Total Ops | -0.25 | -0.12 | -0.24 | -1.27 | -0.29 |
| EPS Diluted Continuous Ops | -0.25 | -0.12 | -0.24 | -1.28 | -0.29 |
| EPS Diluted Before Non-Recurring Items | -0.12 | -0.12 | -0.32 | -1.27 | -0.29 |
| EBITDA(a) | $-8,298 | $-8,892 | $-9,916 | $-38,029 | $-8,009 |